Patent Assignment
Reel/Frame 017300/0929
Assignment of Assignor's Interest
Recorded: 2006-03-01
Pages: 3
Assignors
LEVENTER, STEVE
Executed: 2006-02-23
KUCHARIK, ROBERT
Executed: 2006-02-28
CALCAGNO, JEFF
Executed: 2006-02-23
Assignee
VELA PHARMACEUTICALS, INC.
820 BEAR TAVERN ROAD, SUITE 300, EWING, NEW JERSEY, 08628-1021
Covered Property
(1)
Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof
Application:
11/305,277 →
Publication:
US 2007/0142395
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Correction to Add the Second Assignee to an Assignment Previously Recorded at Reel 017300 Frame 0929.
Mar 16, 2006
From: LEVENTER, STEVE; KUCHARIK, ROBERT; CALCAGNO, JEFF
To: VELA PHARMACEUTICALS, INC.; OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 017345/0401 →
To Add Receiving Party's Address
Jan 3, 2007
From: VELA PHARMACEUTICALS INC.
To: VELA ACQUISITION CORPORATION
Reel/Frame 018700/0352 →